Global Neurovascular Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
“Global Neurovascular Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global neurovascular devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global neurovascular devices market report has been segmented on the basis of product, application, end-use, and region.
Neurovascular devices are used to treat several neurovascular diseases such as atherosclerosis, aneurysms, arteriovenous malformations, etc. that affect nervous system and brain, and the blood vascular system associated with it.
Rising prevalence of neurovascular disorders among individuals across the globe, coupled with rising number of geriatric population are major factors driving growth of the global neurovascular devices market. In addition, increasing demand for minimally invasive surgical procedures is another factor further fueling growth of the global market. Moreover, ongoing product developments and increasing commercialization activities are expected to further drive growth of the global market to a significant extent in the global market during the forecast period.
Stringent regulations and high cost of devices are major factors hampering growth of the global neurovascular devices market. However, rising investments towards expansion and development of advance healthcare infrastructure, especially in developing countries is expected to create lucrative opportunities for major players in the global market over the forecast period.
On the basis of application, the global market is segmented into ischemic strokes, cerebral aneurysms, arteriovenous malformation and fistulas, and others. The others segment includes cerebral artery stenosis, venous sinus thrombosis, and intracranial vascular disease. The ischemic strokes segment accounts for highest revenue share and is expected to maintain its dominance in the global market during the next 10 years. This dominance can be attributed to increasing incidence of strokes among individuals across the globe, owing to unhealthy lifestyle and increasing cases of obesity.
The North America market accounts for highest revenue share in the global neurovascular devices market and is expected to continue its dominance in the global market over the forecast period. Rising prevalence of ischemic stroke, high healthcare spending, and advance healthcare infrastructure are major factors driving growth of the North America neurovascular devices market currently.
The Europe neurovascular devices market is expected to witness significant revenue growth and is projected to register a CAGR of X.X% over the forecast period. The Asia Pacific neurovascular devices market is expected to register highest growth in terms of revenue in the global market. Increasing aging population and rising prevalence of neurovascular diseases in countries in the region are key factors fueling growth of the Asia Pacific neurovascular devices market.
Segmentation on the basis of product:
- Cerebral embolization and aneurysm coiling devices
- Cerebral angioplasty and stenting systems
- Neurothrombectomy devices
- Support devices
Segmentation on the basis of application:
- Ischemic Strokes
- Cerebral Aneurysms
- Arteriovenous Malformation and Fistulas
- Others (cerebral artery stenosis, venous sinus thrombosis, and intracranial vascular disease)
Segmentation on the basis of end-use:
- Ambulatory surgical units
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Stryker Corporation
- Medtronic PLC
- Boston Scientific Corporation
- Johnson & Johnson Services Inc.
- Abbott Laboratories
- Terumo Corporation
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Merit Medical Systems, Inc.
- L. Gore & Associates, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!